Zentalis Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.77 | -$0.77 | -$0.77 |
| Q2 2024 | 4 | -$0.84 | -$0.84 | -$0.84 |
| Q3 2024 | 8 | -$0.98 | -$0.85 | -$0.91 |
| Q4 2024 | 4 | -$0.97 | -$0.97 | -$0.97 |
| Q1 2025 | 4 | -$0.96 | -$0.96 | -$0.96 |
| Q2 2025 | 5 | -$0.98 | -$0.98 | -$0.98 |
| Q3 2025 | 4 | -$0.92 | -$0.92 | -$0.92 |
| Q4 2025 | 5 | -$0.95 | -$0.95 | -$0.95 |
Zentalis Pharmaceuticals, Inc. Earnings Date And Information
Zentalis Pharmaceuticals, Inc. last posted its earnings results on Friday, August 9th, 2024. The company reported $-1.24 earnings per share for the quarter, missing analysts' consensus estimates of $-0.83 by $0.41. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Zentalis Pharmaceuticals, Inc. has generated $-4 earnings per share over the last year ($-4.47 diluted earnings per share) and currently has a price-to-earnings ratio of -1.38. Zentalis Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based on prior year's report dates.
Zentalis Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2024 | Q2 2024 | -$0.83 | -$1.24 | -0.41 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.77 | $0.14 | 0.91 | $40.56 M | |
| 02/27/2024 | Q4 2023 | -$0.92 | -$0.86 | 0.06 | $2.10 M | |
| 11/06/2023 | Q3 2023 | -$1.01 | -$0.79 | 0.22 | $0 | |
| 08/09/2023 | Q2 2023 | -$1.06 | -$1.85 | -0.79 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.96 | -$1.03 | -0.07 | $0 | |
| 03/01/2023 | Q4 2022 | -$1.09 | -$0.81 | 0.28 | $0 | |
| 11/09/2022 | Q3 2022 | -$1.15 | -$0.92 | 0.23 | $0 | |
| 08/09/2022 | Q2 2022 | -$1.21 | -$1.23 | -0.02 | $0 | |
| 05/05/2022 | Q1 2022 | -$1.20 | -$1.27 | -0.07 | $0 | |
| 02/24/2022 | Q4 2021 | -$1.34 | -$1.11 | 0.23 | $0 | |
| 11/10/2021 | Q3 2021 | -$1.31 | -$0.09 | 1.22 | $0 | |
| 08/12/2021 | Q2 2021 | -$1.14 | -$1.34 | -0.2 | $0 | |
| 05/17/2021 | Q1 2021 | -$0.96 | -$1.24 | -0.28 | $0 | |
| 03/25/2021 | Q4 2020 | -$0.97 | -$1.01 | -0.04 | $0 | |
| 11/09/2020 | Q3 2020 | -$0.73 | -$0.91 | -0.18 | $0 | |
| 08/13/2020 | Q2 2020 | -$0.50 | -$0.78 | -0.28 | $0 | |
| 05/15/2020 | Q1 2020 | -$0.70 | -$0.47 | 0.23 | $0 | |
| 12/30/2019 | Q4 2019 | -$0.44 | $0 | |||
| 09/29/2019 | Q3 2019 | -$0.68 | $0 |
Zentalis Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Zentalis Pharmaceuticals, Inc.'s earnings date?
Zentalis Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 8th, 2024 based off last year's report dates.
-
How can I listen to Zentalis Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Zentalis Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Zentalis Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Zentalis Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Zentalis Pharmaceuticals, Inc. generate each year?
Zentalis Pharmaceuticals, Inc. (:ZNTL) has a recorded net income of $0. Zentalis Pharmaceuticals, Inc. has generated $-4.47 earnings per share over the last four quarters.
-
What is Zentalis Pharmaceuticals, Inc.'s price-to-earnings ratio?
Zentalis Pharmaceuticals, Inc. (:ZNTL) has a price-to-earnings ratio of -1.38 and price/earnings-to-growth ratio is -0.08.
